» Articles » PMID: 15689155

Synthesis and Biological Testing of Purine Derivatives As Potential ATP-competitive Kinase Inhibitors

Overview
Journal J Med Chem
Specialty Chemistry
Date 2005 Feb 4
PMID 15689155
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

On the basis of ATP adenine, a series of adenine and purine derivatives was prepared and tested for their ability to inhibit a spectrum of disease-related kinases. There has been scant research investigating the potential of cosubstrate derived kinase inhibitors for other kinases than CDKs. Our inhibitor design combined the purine system from the original cosubstrate ATP and phenyl moieties in order to explore possible interactions with the different regions of the ATP binding site in several disease-related protein kinases. There have been a number of hits for the assayed substances, which led us to conclude that the spectrum of compounds may prove to be a valuable tool kit for the evaluation of bonding and selectivity patterns for a wide variety of kinases.

Citing Articles

Promotion of Water as Solvent in Amination of 4-Chloropyrrolopyrimidines and Related Heterocycles under Acidic Conditions.

Yasuda S, Svergja H, Olsen C, Hoff B ACS Omega. 2024; 9(12):14142-14152.

PMID: 38559978 PMC: 10976386. DOI: 10.1021/acsomega.3c09673.


Recent Developments and Future Perspectives of Purine Derivatives as a Promising Scaffold in Drug Discovery.

Rana N, Grover P, Singh H Curr Top Med Chem. 2024; 24(6):541-579.

PMID: 38288806 DOI: 10.2174/0115680266290152240110074034.


Influence of the Solvent on the Stability of Aminopurine Tautomers and Properties of the Amino Group.

Jezuita A, Wieczorkiewicz P, Krygowski T, Szatylowicz H Molecules. 2023; 28(7).

PMID: 37049758 PMC: 10095612. DOI: 10.3390/molecules28072993.


Antiproliferative Activity, Multikinase Inhibition, Apoptosis- Inducing Effects and Molecular Docking of Novel Isatin-Purine Hybrids.

Alanazi A, Mirgany T, Alsfouk A, Alsaif N, Alanazi M Medicina (Kaunas). 2023; 59(3).

PMID: 36984611 PMC: 10051310. DOI: 10.3390/medicina59030610.


Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia.

Bertrand J, Dostalova H, Krystof V, Jorda R, Delgado T, Castro-Alvarez A Pharmaceutics. 2022; 14(6).

PMID: 35745866 PMC: 9228270. DOI: 10.3390/pharmaceutics14061294.